assess the prevalence of headaches during relapses and remissions of relapsing-remitting MS(RRMS)patients and denote the possible interrelations between headaches and types of MS exacerbations.Methodology & Theoretical…
describe basal characteristics and effectiveness of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS) followed for ≥12 months in routine clinical practice in Spain. Methods: Fingoview is a…
describe basal characteristics and effectiveness of fingolimod in patients with relapsingremitting multiple sclerosis (RRMS) followed for âÂ?¥12 months in routine clinical practice in Spain. Methods: Fingoview is a…
Background: Many patients with relapsing-remitting MS (RRMS) show a suboptimal response to first-line disease-modifying drugs. In these patients treatment with natalizumab is highly effective, however ... them were…
these drugs was assessed in Mexican patients under treatment for relapsing-remitting multiple sclerosis (RRMS). A parallel, multicenter, prospective and comparative study was carried out. Fifty patients with confirmed…
evening primrose oils as well as hot nature dietary intervention in Relapsing Remitting MS (RRMS) patients. Methods and materials: In this double blind, randomized trial, 100 RRMS patients with EDSS ... nature diet can…
topography of bare sBLM in a gel state (T=19ºC) revealed relatively smooth surface (RRMS=0.18 nm) and thickness ~5.1 nm which agrees well with previous studies. Incorporation ... into DMPC bilayer resulted in increase…
clinically different MS subtypes. To this aim, randomly selected each of 11 CIS, RRMS, PPMS and control samples were used to mix pool samples. For both serum and CSF pools ... spots were analyzed with MALDI-TOF-MS. 179…
clinically different MS subtypes. To this aim, randomly selected each of 11 CIS, RRMS, PPMS and control samples were used to mix pool samples. For both serum and CSF pools ... spots were analyzed with MALDI-TOF-MS. 179…
clinically different MS subtypes. To this aim, randomly selected each of 11 CIS, RRMS, PPMS and control samples were used to mix pool samples. For both serum and CSF pools ... spots were analyzed with MALDI-TOF-MS. 179…
present study assessed odour threshold, discrimination and identi fi cation in relapsing-remitting MS (RRMS) pa- tients. We administered the Snif fi n’ Sticks Extended Test (Burghart Messtechnik GmbH, Wedel ... Germany)…
chronic demyelinating disorder of the central nervous system. Relapsing-Remitting MS (RRMS) is the most common type of MS that accounts for 90% of all cases. Recent evidence suggests medium ... DMDs are at a low value…
oral agent approved for the management of relapsing reming mulple sclerosis (RRMS). It was shown to reduce the progression and relapse rate of neurological disability by 30% and 54%, respecvely ... date. We report a…
Comi G, et al. Switching from natalizumab to Fingolimod. A randomized, placebocontrolled study in RRMS. Neurology 2015; 85:29-39 6. Leurs CE, Van Kempen ZL, Dekker
effectiveness of different disease-modifying therapies’ strategies for treatment of relapsing-remitting multiple sclerosis (RRMS) (Figure 1). Methods: A Markov model was developed to assess the cost–effectiveness and…
risk of fingolimod-induced lymphopenia in patients with relapsing-remitting MS multiple sclerosis (RRMS). Methods: Data were obtained from a Trakya University Medical Faculty Neurology Department 47 patient included…
Benign multiple sclerosis (BMS) occurs in about 15% of patients with relapsing-remitting MS (RRMS) that over time do not develop significant neurological disability. Aim of this study ... significant increase in the…
training on lower and hand-grip strength, rachis morphology, flexibility and body balance among RRMS patients. Methods: Twenty-two subjects affected by relapsing-remitting multiple sclerosis (RRMS, EDSS ≤ 6) were
mild MS patients. Methods and materials: In this double blind, randomized trial, 100 RRMS patients (expanded disability status scale<6) allocated into three groups: ?Group A? who received co-supplemented ... diet can…
mild MS patients. Methods and materials: In this double blind, randomized trial, 100 RRMS patients (Expanded Disability Status Scale<6) allocated into three groups: ?Group A? who received co-supplemented ... diet can…
mild MS patients. Methods and materials: In this double blind, randomized trial, 100 RRMS patients (Expanded Disability Status Scale<6) allocated into three groups: Group A who received co-supplemented ... diet can have…
type showed that parity remained a significant predictor of disease progression in relapsing remitting (RRMS) patients, whereas this effect was not observed within progressive subtypes. Conclusions: Our results…
useful as biomarker for MS evolution. Previous to be declared relapsing-remitting MS (RRMS), MS patients suffer a first attack called clinically isolated syndrome (CIS). Since individuals who experience ... level of…
will be described. Th ese biomarkers refl ect the presence of relapsing-remitting MS (RRMS) even when the patient is in remission. Moreover, they can diff erentiate patients in relapse ... opening the possibility to…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.